STAT3 and glioblastoma: Consistent with its role as a GBM driver, constitutive STAT3 activation, evidenced by the Tyrosine 705- or Serine 727-phosphorylation status of STAT3, represents an independent marker for poor prognosis of GBM [6,13,14].